Transition to KPL-387 Monotherapy Dosing & Administration Study

Clinical trial NCT07288216 · RECRUITING

Trial details

NCT number: NCT07288216
Sponsor: Kiniksa Pharmaceuticals International, plc
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Recurrent Pericarditis Heart Diseases Pericarditis

Start date: 2026-03-25
Primary completion: 2027-12-31
Enrollment: 80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.